Ferrous Sulfate

  • TRADE NAMES: Feosol (Meda); Fer-In-Sol (Mead Johnson); Fer-iron; Feratab (Upsher-Smith)
  • INDICATIONS: Iron deficiency anemia
  • CLASS: Iron supplement
  • HALF-LIFE: 6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Antacids, Caffeine, Calcium supplements, Cimetidine, Deferoxamine, Dimercaprol, Etidronate, Fluoroquinolones, Pancreatin, Pancrelipase, Penicillamine, Tetracylines, Trientine, Zinc

PREGNANCY CATEGORY: N/A

Our database has 11 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top